A prospective study of hepatitis C viremia in renal allograft recipients

American Journal of Nephrology

Volumn 19, Issue 5, 1999, Pages 576-585

  Mahmoud, Ihab M ^a   Sobh, Mohamed A ^a   Amer, Galal M ^a   El Chenawy, Farha A ^a   Gazareen, Sanaa H ^a   El Sherif, Assam ^a   El Sawy, Esam ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Hepatitis C virus; Kidney; Transplantation

Indexed keywords

ANTIPARASITIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

ADULT; ARTICLE; DIALYSIS; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHISTOSOMIASIS; SEROPREVALENCE; TIME;

EID: 0032745290     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013523     Document Type: Article

References (50)

1. La Quaglia NP, Tolkoff-Rubin NE, Dienstag JL, Cosini AD, Herrin JT, Kelly M, Rubin RH: Impact of hepatitis on renal transplantation. Transplantation 1981;32:504-507.
2. Mahony JF: Long term results and complications of transplantation: the kidney. Transplant Proc 1989;21:1433-1434.
3. Weir MR, Kirkman RL, Strom TB, Tilney NL: Liver disease in recipients of long-surviving renal allografts. Kidney Int 1985;28:839-844.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-362.
5. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Columbo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
6. Pereira BJG: Hepatitis C in organ transplantation - its significance and influence on transplantation policies. Curr Op Nephrol Hypertens 1993;2:912-922.
7. Tamura I, Kobayashi Y, Koda T, Ichimura H, Kurimura O, Takasugi T, Kurimura T: Hepatitis C virus in hemodialysis patients. Lancet 1990;335:1409.
8. Ponz E, Campistol JM, Bruguera M, Barrera JM, Gil C, Pinto JB, Andreu J: Hepatitis C virus infection among renal transplant recipients. Kidney Int 1991;40:748-751.
9. Jadoul M, Cornu C, Van Ypersele De Strihou C, and the UCL collaborative group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993;44:1322-1326.
10. Roth D, Fernandez JA, Babischkin S, Demattos A, Buck BE, Quan S, Olson L, Burke GW, Nery J, Esquenazi V, Schiff ER, Miller J: Detection of hepatitis C virus infection among cadaver organ donors: Evidence for low transmission of disease. Ann Intern Med 1992;117: 470-475.
11. Aeder MI, Shield CF, Tegtmeier GE, Bayer W, Luger AM, Nelson PW, Pierce GE, Polito A, Wilber JC, Johnson PJ, Ross G, Bryan CF: The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 1993;25: 1469-1471.
12. Pol S, Legendre C, Saltiel C, Carnot F, Brechot C, Berthelot P, Mattlinger B, Kreis H: Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. J Hepatol 1992;15:202-206.
13. Klauser R, Franz M, Traindl O, Pidlich J, Hay U, Watschinger B, Pohanda E, Kowarck J: Hepatitis C antibody in renal transplant patients. Transplant Proc 1992;24:286-288.
14. Stempel CA, Lake J, Kuo G, Vincenti F: Hepatitis C - its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993;55:273-276.
15. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R: Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival - A 5-and 10-year follow-up. Transplant Proc 1993; 25:1466-1468.
16. Pereira BJG, Wright TL, Schmid CH, Levey AS: The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995;60:799-805.
17. Pouteil-Noble C, Tardy JC, Chossegros P, Trepo C, Aymard M, Touraine JL: Anti-hepatitis C virus antibodies: Prevalence and morbidity in renal transplantation; in Touraine J, Traeger J, Betuel H (eds): Transplantation and Clinical Immunology. Virus and Transplantation; Proceedings of the 32nd International Course, Lyon, 3-5 June 1991. Amsterdam, Excerpta Medica, 1991, pp 81-86.
18. Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994;45:238-244.
19. Genesca J, Villa J, Cordoba J, Sauleda S, Ouer J, Esteban JI, Esteban R, Piera L, Guardia J: Hepatitis C virus in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol 1995;22:272-277.
20. Bukh J, Wantzin P, Krogsgaard K, Purcell RH, Miller RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. JID 1993;168:1343-1348.
21. Lau J, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC: Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993;18:1027-1031.
22. Pereira BJG, Milford EL, Kirkman RL, Sayre KR, Johnson PJ, Wilber JC, Quan S, Levey AS: Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients. N Engl J Med 1992;327:910-915.
23. Rautenberg P, Schneppenheim R, Leimenstoll G, Behnke H, Loose G: Discrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapy. Eur J Clin Microbiol Infect Dis 1991;10:978-981.
24. Morales JM, Campistol JM, Castellano G, Andres A, Colina F, Fuertes A, Ercilla G, Bruguera M, Andreu J, Carretero P, Rodicio JL, Levey AS, Pereira BJG: Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995;47:236-240.
25. Huang C, Lai M, Lin M, Pao C, Fang J, Yao D: Transmission of hepatitis C virus by renal transplantation. Transplant Proc 1993;25: 1474-1475.
26. Mendez R, Aswad S, Bogaard T, et al: Donor hepatitis C antibody virus testing in renal transplantation. Transplant Proc 1993;25: 1487-1490.
27. Tesi R, Henry M, Elkhammas E, Ferguson R: Prospective study of use of low risk HCV positive donors for kidney transplantation (abstract). In XIVth International Congress of The Transplantation Society, Paris, 1992, p 233.
28. Huraib S, Al-Rashed R, Aldrees A, Aljefry M, Arif M, Al-Faleh A: High prevalence of and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-474.
29. Dentico P, Volpe A, Buongiorno R, Carlone A, Carbone M, Manno M: Hepatitis C virus in hemodialysis patients. Nephron 1992;61:307-308.
30. Knudsen F, Wantzin P, Rasmussen K, Ladeforrd SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993;43: 1353-1356.
31. Chauveau P, Courouce AM, Lemarec N, Naret C, Poignet JL, Girault A, Remadame M, Delons S: Antibodies to hepatitis C virus by second generation test in hemodialysed patients. Kidney Int 1993;43:S149-S152.
32. Darwish MA, Raouf TA, Tushdy P, Constantine NT, Rao MR, Edelman R: Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993;49(4):440-447.
33. Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increase with time on dialysis. Clin Nephrol 1992;38:44-48.
34. Capron A, Bignet J, Vernes A, Afchain D: Antigenie structure of helminthes. Immunologic aspects of parasitic infections. Pathol Biol 1971; 16:121-138.
35. Sher A, Butterworth AE, Colley DG: Immune response during human schistosomiasis mansoni. Occurrence of eosinophil dependent cytotoxic antibodies in relation to intensity and duration of infection. Am J Trop Med Hyg 1977;26:909-916.
36. Nash TE: Localization of circulating antigen within the gut of schistosoma mansoni. Am J Trop Med Hyg 1970;23:1085-1089.
37. Huang CC, Liaw YF, Lai MK, Chu SH, Chuang CK, Huang JY: The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992;53: 763-765.
38. Pereira BJG, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454-460.
39. Morales JM, Campo C, Castellano G, Colina F, Andres A, Fuertes A, Praga M, Rodicio JL: Clinical implications of the presence of antibodies to hepatitis C after renal transplantation. Transplant Proc 1992;24:78-80.
40. Morales JM, Munoz MA, Castellano G, Colina F, Fuertes A, Andres A, Campo C, Blasco A, Hernandez E, Rodicio JL: Impact of hepatitis C in long-functioning renal transplants: A clinicopathological follow-up. Transplant Proc 1993;25:1450-1453.
41. Chan TM, Lok ASF, Cheng IKP, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993;104:862-868.
42. Coffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, Van Ypersele De Strihou C: Outcome of HCV infection after renal transplantation. Kidney Int 1994;45:551-555.
43. Roth D: Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995;23:3-16.
44. Zylberberg H, Carnot F, Mamzer MF, Blancho G, Legendre C, Pol S: Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997;63(1):158-160.
45. Atkinson K, Biggs J, Dodds A, Concannon A: Cyclosporine-associated hepatotoxicity after allogenic marrow transplantation in man: Differentiation from other causes of posttransplant liver disease. Transplant Proc 1983; 15(1):545.
46. Ramalho HJ, Terra EG, Cartapatti E, Barberato JB, Alves VA, Gayotto LC, Abbud-Filho M: Hepatotoxicity of azathioprine in renal transplant recipients. Transplant Proc 1989;21: 1716.
47. Pol S, Cavalcanti R, Carnot F, Legendre C, Driss F, Chaix ML, Thervet E, Chkoff N, Brechot C, Berthelot P, Kreis H: Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis. Transplantation 1996;61(12):1774-1776.
48. Pallardo LM, Gorriz JL, Sanchez J, Sanchez P, Ballester M, Rochera A: Liver disease associated with hepatitis C virus antibodies in renal transplant patients. Analysis of risk factors and prognostic significance. 6th Congress of European Society for Organ Transplantation. Rodos, 185 (abstract), 1993.
49. Gorriz JL, Pallardo LM, Sarrion A, Sanchez J, Rochera A: Hepatitis C virus infection in renal transplant recipients: Prognostic significance of chronic transaminase elevation. Transplant Proc 1995;27(4):2250-2251.
50. Munoz De Bustillo E, Ibarrola C, Colina F, Castellano G, Fuertes A, Andres A, Aguado JM, Rodicio JL, Morales JM: Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol 1998;9(6):1109-1113.